| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 17.5MM | +6% |
| Gross Profit | 13.4MM | +4% |
| Cost Of Revenue | 4MM | +10% |
| Operating Income | 5.2MM | -13% |
| Operating Expenses | 8.3MM | +19% |
| Net Income | 4.5MM | -10% |
| R&D | 650.4K | +44% |
| G&A | 4.3MM | +18% |
| Marketing | 3.3MM | +16% |
| Amortization | 41.3K | +64% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
IRADIMED (NASDAQ:IRMD) has had a rough three months with its share price down 7.0%. But if you pay close attention, you...
WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at https://www.iradimed.com/investors/events. This ye
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...
Key Insights The projected fair value for IRadimed is US$35.82 based on Dividend Discount Model IRadimed's US$42.39...
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Despite growing by 12.70% net of fees in the fourth quarter, the strategy was unable to match the 15.64% return of the Russell Micro Cap Growth Index. Underperformance was mostly caused […]
Key Insights Institutions' substantial holdings in IRadimed implies that they have significant influence over the...
IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript February 8, 2024 IRadimed Corporation beats earnings expectations. Reported EPS is $0.39, expectations were $0.37. IRMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the IRadimed Corporation Fourth Quarter of […]
Company Initiates Quarterly Dividend Following a Strong Fiscal Performance
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.48 for the full year of 2023. Reports fourth quarter of 2023 operating income of $5.2 million, an increase of 21.3%, compared to the same period in 2022 and full-year operating income of $20.0 million, an increase of 28.2%, com